Nadler and Democrats must zero in on corporate power: Look at prescription drug pricing and megamergers

The midterm election that propelled Democrats to a majority in the House of Representatives revealed voter sentiment on a number of fronts that should inform the House Judiciary Committee’s first 100 days under its likely new leader, New York Rep. Jerrold Nadler (D-NY), including on antitrust and competition policy.

Read More

NY Times Op-ed on Trump Is Historical Anomaly, Attorney Goodfriend Says

David Goodfriend, of counsel to Weiner, Brodsky, Kider and former deputy staff secretary to President Bill Clinton, discusses the New York Times op-ed by an unidentified senior administration official that said some of President Donald Trump's closest advisers are working in secret to thwart his "more misguided impulses." He speaks with Bloomberg's David Westin and Shery Ahn on "Bloomberg Markets: Balance of Power."

Read More